249 related articles for article (PubMed ID: 27455021)
1. [Application of CRISPR-Cas9 genome editing for constructing animal models of human diseases].
Ou Z; Sun X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Aug; 33(4):559-63. PubMed ID: 27455021
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
3. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
4. RNA-guided genome editing in plants using a CRISPR-Cas system.
Xie K; Yang Y
Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
[TBL] [Abstract][Full Text] [Related]
5. Exogenous gene integration mediated by genome editing technologies in zebrafish.
Morita H; Taimatsu K; Yanagi K; Kawahara A
Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
[TBL] [Abstract][Full Text] [Related]
6. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
Yin LJ; Hu SQ; Guo F
Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
8. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
9. Both CRISPR/Cas-based nucleases and nickases can be used efficiently for genome engineering in Arabidopsis thaliana.
Fauser F; Schiml S; Puchta H
Plant J; 2014 Jul; 79(2):348-59. PubMed ID: 24836556
[TBL] [Abstract][Full Text] [Related]
10. The CRISPR/Cas system can be used as nuclease for in planta gene targeting and as paired nickases for directed mutagenesis in Arabidopsis resulting in heritable progeny.
Schiml S; Fauser F; Puchta H
Plant J; 2014 Dec; 80(6):1139-50. PubMed ID: 25327456
[TBL] [Abstract][Full Text] [Related]
11. Genome editing using Cas9 nickases.
Trevino AE; Zhang F
Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas-mediated targeted genome editing in human cells.
Yang L; Mali P; Kim-Kiselak C; Church G
Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
[TBL] [Abstract][Full Text] [Related]
13. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
14. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
15. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.
LaFountaine JS; Fathe K; Smyth HD
Int J Pharm; 2015 Oct; 494(1):180-94. PubMed ID: 26278489
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9: a new and promising player in gene therapy.
Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
[TBL] [Abstract][Full Text] [Related]
17. Engineering the Caenorhabditis elegans genome with CRISPR/Cas9.
Waaijers S; Boxem M
Methods; 2014 Aug; 68(3):381-8. PubMed ID: 24685391
[TBL] [Abstract][Full Text] [Related]
18. Designed nucleases for targeted genome editing.
Lee J; Chung JH; Kim HM; Kim DW; Kim H
Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
20. Application of genome editing technologies to the study and treatment of hematological disease.
Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
